Phase II study of antineoplastons A10 and AS2-1 in patients with bronchial alveolar carcinoma of the lung
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 30 Jan 2018 Status changed from active, no longer recruiting to discontinued due to slow accrual.
- 04 Sep 2005 New trial record.